Acutus Medical (AFIB) Competitors $0.0005 0.00 (-75.00%) As of 10/16/2025 03:20 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock AFIB vs. SDCCQ, GMVDF, VRAYQ, NMRD, UTRS, MOTS, VIVE, DRTSW, ANZUW, and ATAKWShould you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Aurora Technology Acquisition (ATAKW). These companies are all part of the "medical equipment" industry. Acutus Medical vs. Its Competitors SmileDirectClub G Medical Innovations ViewRay Nemaura Medical Minerva Surgical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition SmileDirectClub (NASDAQ:SDCCQ) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership and earnings. Do insiders and institutionals believe in SDCCQ or AFIB? 0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer SDCCQ or AFIB? In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score. Company Overall Sentiment SmileDirectClub Neutral Acutus Medical Neutral Is SDCCQ or AFIB more profitable? SmileDirectClub has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. SmileDirectClub's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets SmileDirectClubN/A N/A N/A Acutus Medical -272.74%-311.64%-11.57% Which has preferable valuation and earnings, SDCCQ or AFIB? Acutus Medical has lower revenue, but higher earnings than SmileDirectClub. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmileDirectClub$470.74M0.00-$86.40MN/AN/AAcutus Medical$7.16M0.00-$81.66MN/AN/A Which has more risk and volatility, SDCCQ or AFIB? SmileDirectClub has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.67, indicating that its stock price is 167% less volatile than the S&P 500. SummarySmileDirectClub beats Acutus Medical on 6 of the 9 factors compared between the two stocks. Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart AFIB vs. The Competition Export to ExcelMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$15K$80.87M$6.09B$10.55BDividend YieldN/AN/A5.73%4.78%P/E RatioN/A9.9485.0827.19Price / Sales0.0041.79604.99132.96Price / CashN/A18.4137.8662.13Price / Book-0.0218.5012.396.65Net Income-$81.66M-$27.88M$3.32B$276.79M7 Day PerformanceN/A8.59%2.31%1.75%1 Month PerformanceN/A12.35%9.68%5.15%1 Year PerformanceN/A68.24%73.81%36.96% Acutus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFIBAcutus MedicalN/A$0.00-75.0%N/A-99.7%$15K$7.16M0.00340Gap DownSDCCQSmileDirectClubN/A$0.00flatN/A-50.0%$40K$470.74M0.002,700GMVDFG Medical InnovationsN/A$0.00flatN/A+0.0%$26K$4.42M0.0072VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300NMRDNemaura Medical0.9685 of 5 stars$0.00flatN/AN/A$4K$3.02K0.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160MOTSMotus GI0.0324 of 5 stars$0.00flatN/AN/A$1K$319K0.0030VIVEViveve MedicalN/A$0.00-50.0%N/AN/A$1K$6.83M0.0070Gap DownDRTSWAlpha Tau MedicalN/A$0.36-8.2%N/A+64.4%$0.00N/A0.0080Positive NewsGap DownANZUWAnzu Special Acquisition Corp IN/A$0.04flatN/A-10.5%$0.00N/A0.002Gap DownATAKWAurora Technology AcquisitionN/A$0.01-34.1%N/A-40.9%$0.00N/A0.00N/AGap Down Related Companies and Tools Related Companies SDCCQ Competitors GMVDF Competitors VRAYQ Competitors NMRD Competitors UTRS Competitors MOTS Competitors VIVE Competitors DRTSW Competitors ANZUW Competitors ATAKW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFIB) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
